Celldex Therapeutics shares owned by Legal & General Group
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Legal & General Group
from 13F filings
Historical chart of Legal & General Group investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Celldex Therapeutics by Legal & General Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $2.1M | 52k | 39.66 |
2023-09-30 | $1.1M | 41k | 27.52 |
2023-06-30 | $1.3M | 37k | 33.93 |
2023-03-31 | $677k | 19k | 35.98 |
2022-12-31 | $767k | 17k | 44.57 |
2022-09-30 | $474k | 17k | 28.13 |
2022-06-30 | $435k | 16k | 26.96 |
2022-03-31 | $572k | 17k | 34.07 |
2021-12-31 | $638k | 17k | 38.60 |
2021-09-30 | $920k | 17k | 54.85 |
2021-06-30 | $206k | 6.1k | 33.76 |
2021-03-31 | $35k | 1.7k | 20.58 |
2020-12-31 | $30k | 1.7k | 17.64 |